All our latest news

Discover the vision and goals of Crux Biolabs' new CEO in our in-depth interview. Learn about their background in the pharmaceutical industry and the company's plans for expanding bioanalytical services in Australia's R&D landscape.

MesoScale Discovery (MSD) immunoassays are used to measure the concentration of proteins or other molecules in biological samples. They detect multiple analytes in a single sample and are superior to Luminex because of a wider dynamic range, reduce matrix effects and increase sensitivity. MSD assays…

When it comes to clinical trials, it is all about the patient! Good Clinical Practice – or GCP as it is known - is a must for biolabs to ensure that their clinical trials are conducted ethically and scientifically. This…

When it comes to places to conduct research, few places globally offer better incentives than Australia. Known as the “Australian advantage”, not only does the land down under offer a fast and pragmatic regulatory environment for clinical studies (with a…

As so many of our partners have thrilled since earlier in the year when we launched our capability to provide 21 colour flow cytometry, we just had to do a shout out to it. As you no doubt know, flow…

After repeated inquiries from our customer base, Crux Biolabs are pleased to announce their expansion into chemistry analytical services in 2023. These services will be centred around UHPLC and LCMS instrumentation to be installed in our new, purpose-built lab space.…

We are pleased to be attending AusBiotech 2022 in Perth! If you are also attending this year's event, get in touch with any of our team here as we would love to connect and get to know you better.

Genesis Capital invests in Crux Biolabs, a leading bioanalytical laboratory to the clinical trials sector  Crux Biolabs is a decade-old Australian leader in bioanalytics, customised biomarker detection, cell assay development, clinical and pre-clinical testing with particular strength in the immuno-oncology…

Crux Biolabs has recently passed 2 External Quality Assurance Programs (EQAPs) and we’d like to congratulate the fantastic scientists involved. Livleen Kaur successfully passed Crux’s 2nd consecutive participation in the international Duke University EQAPOL for Luminex with a staggering score…

We're hiring again! Are you a gun at flow cytometry?Are you sick of short-term academic contracts?Maybe you could be Crux's Senior Immunology Scientist, a newly created permanent position, in our growing contract research team to work on cutting-edge immunotherapy clinical…